WaveMan
WaveMan · Company
ALHC · Alignment Healthcare, Inc.
> Search tickers & screens ⌘K
LIVE
← All companies

ALHC Alignment Healthcare (ALHC) Insider Trading, Ownership & Congress Trades

Insurance · Hospital & medical service plans · CIK 0001832466
Quote by TradingView
C-suite buying · 1Form 144 · 6
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
225
13F, latest reported quarter
Conversions, 180 days
1
Codes C/M, not in net · $1.4M priced

What the filings say about ALHC

Insiders, 180 days
-$38.3M net sold
1 buyer · 4 sellers · 14% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$14.1M
6 notices

Alignment Healthcare insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

Over the last 180 days, Alignment Healthcare, Inc. insiders sold a net $38.3M of stock across 388 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-27.

Insider
Filed
Shares
Value
Since filing
Kim Hyong
Chief Medical Officer
SELL
2026-10-07 SECtraded 2026-10-06
32,479
$269.6K
-9.4%
Context
  • 20 earlier Form 4 trades (code P or S) here by this insider (20 sales), the last on Jun 12, 2026.
  • The trade is 10.9% of the 299,271 shares held after it.
  • 3 other insiders sold within 30 days.
  • 225 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Medical Officer Kim Hyong sold about $269.6K of ALHC on Oct 6, 2026; 3 other insiders sold within 30 days and 225 funds added in the latest 13F quarter.
KONOWIECKI JOSEPH S
EVP, Corporate Affairs
SELL
2026-09-18 SECtraded 2026-09-17
23,511
$202.4K
-5.3%
Context
  • 20 earlier Form 4 trades (code P or S) here by this insider (1 buy, 19 sales), the last on Jul 1, 2026.
  • The trade is 2.2% of the 1,080,305 shares held after it.
  • 3 other insiders sold within 30 days.
  • 225 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP, Corporate Affairs KONOWIECKI JOSEPH S sold about $202.4K of ALHC on Sep 17, 2026; 3 other insiders sold within 30 days and 225 funds added in the latest 13F quarter.
KAO JOHN E
Chief Executive Officer
SELL
2026-09-16 SECtraded 2026-09-14
27,400
$356.2K
-9.3%
Context
  • 77 earlier Form 4 trades (code P or S) here by this insider (1 buy, 76 sales), the last on Sep 11, 2026.
  • The trade is 4.6% of the 590,766 shares held after it.
  • 3 other insiders sold within 30 days.
  • 225 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer KAO JOHN E sold about $356.2K of ALHC under a 10b5-1 plan on Sep 14, 2026; 3 other insiders sold within 30 days and 225 funds added in the latest 13F quarter.
KAO JOHN E
Chief Executive Officer
SELL
2026-09-11 SEC
385,270
$4.9M
-39.0%
Context
  • 76 earlier Form 4 trades (code P or S) here by this insider (1 buy, 75 sales), the last on Sep 10, 2026.
  • The trade is 31.5% of the 1,223,473 shares held after it.
  • 3 other insiders sold within 30 days.
  • 225 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer KAO JOHN E sold about $4.9M of ALHC under a 10b5-1 plan on Sep 11, 2026; 3 other insiders sold within 30 days and 225 funds added in the latest 13F quarter.
Maroney Dawn Christine
President
SELL
2026-09-11 SEC
122,707
$1.6M
-39.0%
Context
  • 73 earlier Form 4 trades (code P or S) here by this insider (73 sales), the last on Aug 14, 2026.
  • The trade is 15.4% of the 794,606 shares held after it.
  • 3 other insiders sold within 30 days.
  • 225 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President Maroney Dawn Christine sold about $1.6M of ALHC on Sep 11, 2026; 3 other insiders sold within 30 days and 225 funds added in the latest 13F quarter.
388 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to see 383 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
net -$38.3M over 180 days
-$13.7M over 90 days
below 88% of Insurance
Congress
no House purchase disclosed in the last 12 months
Funds
225 funds bought in last quarter
more than 64% of Insurance
Revenue
+46.1% year over year
more than 89% of Insurance
Margin
0.0% net margin
below 83% of Insurance
Buybacks
no share repurchases reported
Short interest
12.5% of the float short (float per yahoo 2026-10-26) · 1.6 days to cover · settled 2026-09-30
more than 96% of Insurance
What changed in the last 30 days
Oct 7Chief Medical Officer Kim Hyong sold $269.6K (Oct 6)
Oct 5Chief Medical Officer Hyong (Ken) Kim, M.D. filed to sell $305.3K by Oct 6 (Form 144)
Why it matters
A Form 144 is a notice of intent to sell; the sale may not happen, and it says nothing about the price.

Watch ALHC

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-54.6%12M
-57%-24%+9%+41%2025-102025-122026-022026-042026-062026-082026-10 2025-12-12 · General Atlantic (ALN HLTH), L.P. sold $206.5M2025-12-12 · GENERAL ATLANTIC GENPAR, L.P. sold $206.5M2025-12-29 · KAO JOHN E sold $10.7M2026-07-10 · KAO JOHN E sold $5.5M2025-12-29 · Maroney Dawn Christine sold $5.0M2026-09-11 · KAO JOHN E sold $4.9M2026-01-06 · Maroney Dawn Christine sold $4.9M2026-05-11 · KAO JOHN E sold $4.7M2026-06-10 · KAO JOHN E sold $4.6M2026-04-10 · KAO JOHN E sold $4.2M2026-08-10 · KAO JOHN E sold $4.1M2026-01-12 · KAO JOHN E sold $3.7M2026-02-10 · KAO JOHN E sold $3.7M2026-07-15 · Maroney Dawn Christine sold $3.7M2025-12-10 · KAO JOHN E sold $3.4M2026-03-10 · KAO JOHN E sold $3.3M2025-11-10 · KAO JOHN E sold $2.9M2026-04-07 · KAO JOHN E sold $2.7M2026-04-07 · KAO JOHN E sold $2.5M2025-12-15 · Maroney Dawn Christine sold $2.3M2026-09-10 · KAO JOHN E sold $2.2M2026-03-23 · KAO JOHN E sold $2.1M2026-01-02 · Maroney Dawn Christine sold $2.0M2026-04-13 · KAO JOHN E sold $1.7M2026-09-11 · Maroney Dawn Christine sold $1.6M2026-06-10 · KAO JOHN E sold $1.5M2026-03-18 · KAO JOHN E sold $1.3M2025-12-29 · Scavo Robert L. sold $1.2M2026-03-12 · KAO JOHN E sold $803.0K2026-06-12 · Kim Hyong sold $714.0K2026-03-18 · Maroney Dawn Christine sold $655.6K2025-12-29 · KAO JOHN E sold $643.6K2026-04-15 · Maroney Dawn Christine sold $626.1K2026-02-17 · Maroney Dawn Christine sold $618.9K2026-07-01 · KONOWIECKI JOSEPH S sold $600.0K2026-06-15 · Maroney Dawn Christine sold $586.5K2026-06-26 · KONOWIECKI JOSEPH S sold $575.0K2026-06-18 · KONOWIECKI JOSEPH S sold $550.0K2026-06-11 · KONOWIECKI JOSEPH S sold $525.0K2026-03-16 · Maroney Dawn Christine sold $524.4K2026-05-15 · Maroney Dawn Christine sold $482.7K2026-03-12 · Maroney Dawn Christine sold $478.1K2026-10-05 · Hyong (Ken) Kim, M.D. filed to sell $305.3K2026-09-16 · Joseph Konowiecki filed to sell $226.5K2026-09-10 · JEK TRUST U/A DTD 02/08/2021 filed to sell $6.5M2026-09-09 · John Kao filed to sell $5.3M2026-09-09 · Dawn C. Maroney filed to sell $1.7M2026-08-14 · DAWN MARONEY filed to sell $67.3K2026-07-15 · DAWN MARONEY filed to sell $3.8M2026-07-10 · JEK TRUST U/A DTD 02/08/2021 filed to sell $12.5M2026-07-01 · Joseph Konowiecki filed to sell $600.0K2026-06-26 · Joseph Konowiecki filed to sell $575.0K2026-06-18 · Joseph Konowiecki filed to sell $550.0K
Insider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns ALHC: institutional holders (13F)

13F holdings, latest reported quarter
BlackRock, Inc.
19,342,956 sh
$460.6M
WELLINGTON MANAGEMENT GROUP LLP
18,780,363 sh
$447.2M
FMR LLC
13,924,329 sh
$331.5M
VANGUARD PORTFOLIO MANAGEMENT LLC
11,672,259 sh
$277.9M
Invesco Ltd.
10,365,640 sh
$246.8M

Congress trades in ALHC

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

ALHC planned insider sales (Form 144)

Notice of intent to sell, filed before any sale
Hyong (Ken) Kim, M.D.
Filed 2026-10-05
$305.3K
Joseph Konowiecki
Filed 2026-09-16
$226.5K
JEK TRUST U/A DTD 02/08/2021
Filed 2026-09-10
$6.5M
John Kao
Filed 2026-09-09
$5.3M
Dawn C. Maroney
Filed 2026-09-09
$1.7M

ALHC mutual fund holders (N-PORT)

Funds ranked by the share of their own portfolio in this stock (N-PORT).
RiverPark/Next Century Growth Fund
$425.9K position · as of 2026-06-30
3.5%
Osterweis Opportunity Fund
$11.0M position · as of 2026-06-30
2.9%
Global X HealthTech ETF
$679.4K position · as of 2026-05-31
2.7%
Select Health Care Services Portfolio
$20.8M position · as of 2026-05-31
2.6%
BNY Mellon Small/Mid Cap Growth Fund
$19.9M position · as of 2026-06-30
2.3%
Allspring SMID Core ETF
$2.5M position · as of 2026-06-30
2.2%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M · % is the share of the fund's own portfolio
Executive pay vs shareholder return · Mr. Kao
CEO pay, headline and as actually paid, against the company's return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$11.3M
$52.3M
$3.6M
+14%
+1%
2024
$6.4M
$25.2M
$2.7M
-35%
-18%
2023
$14.3M
-$2.7M
$4.8M
-50%
-17%
2022
$34.1M
$25.8M
$7.3M
-32%
-22%
2021
$46.0M
$37.3M
$10.9M
-19%
-2%
Tagged by the company under SEC Item 402(v). Returns are cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $38.3M sold by insiders over 180 days, 225 funds added last quarter, $14.1M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
GSHDDGICAPLMRCRVLHGTYKNSLAFLTRVMKLOSCRGLTRUP

ALHC financials

Revenue growth
+46.1%
XBRL, annual
Net margin
0.0%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$4.6B
four quarters, 2025-07-01 to 2026-06-30
Net margin, TTM
+0.9%
net income over revenue, 2025-07-01 to 2026-06-30
Free cash flow, TTM
$177.5M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Debt to equity
1.22x
long-term 2026-06-30 plus current 2026-06-30; equity 2026-06-30
Cash flow to debt
0.63x
TTM operating cash flow over long-term 2026-06-30 plus current 2026-06-30
Return on equity
+20.0%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets
+3.6%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on invested capital
n/a
effective tax rate -5%, not meaningful
Return on capital employed
+10.3%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
P/E, trailing
41.53x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
Enterprise value
$1.3B
market value at close 2026-10-26 on 2026-07-27 shares, plus long-term 2026-06-30 plus current 2026-06-30, minus cash 2026-06-30
FCF yield
+10.8%
TTM free cash flow over market value at close 2026-10-26
PEG, trailing
n/a
prior-year trailing EPS was a loss, growth undefined
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-122022-12
Revenue$3.9B$2.7B$1.8B$1.4B
Operating income$14.8M-$101.6M-$127.8M-$128.6M
Net income-$724.0K-$128.0M-$148.0M-$149.5M
EPS (diluted)0.00-0.67-0.79-0.83
Operating cash flow$139.9M$34.8M-$59.2M-$45.4M
Cash$575.8M$432.9M$202.9M$409.5M
Long-term debt$323.2M$321.4M$161.8M$160.9M
SEC XBRL, fiscal years, as known on 2026-10-27

ALHC Stock Sonar score 6/7 axes

Find similar shapesCompare

ALHC ranks highest on growth (89th percentile) and profitability (66th), and lowest on financial health (30th), among Insurance peers.

ProfitHealthGrowthInsidersInstitutionsRisk
Profitability
66
Inputs
  • Return on equity+20.0% · 69 pct, sector of 116
  • Return on assets+3.6% · 55 pct, sector of 122
  • Return on invested capitaleffective tax rate -5%, not meaningful
  • Return on capital employed+10.3% · 75 pct, universe of 3,236
Financial health
30
Inputs
  • Debt to equity1.22x · 9 pct, sector of 104
  • Cash flow to debt0.63x · 52 pct, sector of 97
Growth
89
Inputs
  • Revenue growth, YoY+46.1% · 89 pct, sector of 134
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
37
Inputs
  • Net Form 4 buying (codes P and S), 180d-$30.8M · 12 pct, sector of 100
  • Insider buyers, 180d1 · 62 pct, sector of 101
Institutional and government
54
Inputs
  • Funds adding, latest quarter225 · 64 pct, sector of 108
  • Congress net buyers, 365dno Congress trades in 365 days
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quarters$255K · 44 pct, sector of 35
Risk and compliance
34
Inputs
  • Short interest, % of float+12.5% · 4 pct, sector of 138
  • Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
  • EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
  • New text in Risk Factors, latest 10-K+8.1% · 64 pct, sector of 110
1 not measured: US patents
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

ALHC filings, in plain words

Are Alignment Healthcare insiders buying or selling ALHC?

In the 180 days to 2026-10-27, Alignment Healthcare insiders were net sellers, a net $38.3M: $197.6K of purchases and $38.5M of sales reported on Form 4, by 1 buyer and 4 sellers.

Are there planned insider sales of ALHC?

Yes. 6 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-27, covering $14.1M of stock; the latest, by Hyong (Ken) Kim, M.D., was filed 2026-10-05.

Read the full summary

In the 180 days to 2026-10-27, Alignment Healthcare insiders were net sellers of ALHC, a net $38.3M across purchases and sales reported on Form 4 by 1 buyer and 4 sellers. Sales outweighed purchases more than tenfold by value. 14% of the 22 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. Insiders filed 6 Form 144 notices of intent to sell in the 90 days to 2026-10-27, covering $14.1M of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies